Piramal Pharma Limited (NSEI: PPLPHARMA)
Health Care · Pharmaceuticals · IN
Rs196.88
-0.55% today · -0.4% 1Y
Piramal Pharma Limited (NSEI: PPLPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.70B and employs 7,120 people.
Over the last twelve months the share price has lost 0.4%, trading between 132.30 and 231.93.
Tweenvest scores Piramal Pharma Limited across four factors: quality 64/100, value 35/100, growth 63/100. Its strongest factor is quality.
PPLPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.70B
- Revenue (TTM)
- $973.57M
- P/E
- —
- EPS
- -2.36
- Dividend yield
- —
- Beta (5Y)
- 0.34
- 52-week high
- Rs231.93
- 52-week low
- Rs132.30
- Avg volume (3M)
- —
- Shares outstanding
- 1.33B
- Employees
- 7,120
- Next earnings
- —
About Piramal Pharma Limited
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.
- ISIN
- INE0DK501011
- Founded
- 2020
- Listed since
- Oct 19, 2022
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kangmei Pharmaceutical Co., Ltd.SHSE: 600518 | $2.79B | CN¥1.35 | +0.75% |
| Harbin Pharmaceutical Group Co., Ltd.SHSE: 600664 | $2.78B | CN¥7.39 | -0.14% |
| Neuland Laboratories LimitedBSE: 524558 | $2.77B | Rs20,879.85 | -2.87% |
| Joincare Pharmaceutical Group Industry Co.,Ltd.SHSE: 600380 | $2.77B | CN¥10.13 | +2.32% |
| Acutaas Chemicals LimitedNSEI: ACUTAAS | $2.67B | Rs3,160.60 | -1.12% |
| Rubicon Research LimitedNSEI: RUBICON | $2.65B | Rs1,548.50 | -5.05% |
| MBX Biosciences, Inc.NasdaqGS: MBX | $2.56B | $53.24 | -9.01% |
| China Resources Double-Crane Pharmaceutical Co.,Ltd.SHSE: 600062 | $2.53B | CN¥16.44 | +1.23% |
Figures last refreshed Oct 11, 2026.